Citations

Showing 10 of 108094 citations.

Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia—Reply
Kapoor, Prashant , Ansell, Stephen M. , Gertz, Morie A.

Mayo Clinic

JAMA Oncology | February 1, 2018 | Volume: 4 | Issue: 5 | Pages: 745

10.1001/jamaoncol.2017.5100 | PMID 29392293 Get It

Prothrombin Complex Concentrate Reversal of Coagulopathy in Emergency General Surgery Patients
Younis, Moustafa , Ray-Zack, Mohamed D. , Haddad, Nadeem N. , Choudhry, Asad , Wise, Kevin B., Zielinski, Martin D. , Ray-Zack, Mohamed, Hernandez, Matthew C. , Wise, Kevin

Mayo Clinic

World Journal of Surgery | February 1, 2018 | Volume: 42 | Issue: 8 | Pages: 2383-2391

10.1007/s00268-018-4520-2 | PMID 29392436 Get It

AbstractBackgroundCoagulopathy can delay or complicate surgical diseases that require emergent surgical treatment. Prothrombin complex concentrates (PCC) provide concentrated coagulation factors which may reverse coagulopathy more quickly than plasma (FFP) alone. We aimed to determine the time to operative intervention in coagulopathic emergency general surgery patients receiving either PCC or FFP. We hypothesize that PCC administration more rapidly normalizes coagulopathy and that the time to operation is diminished compared to FFP alone.MethodsSingle institution retrospective review was performed for coagulopathic EGS patients during 2/1/2008 to 8/1/2016. Patients were divided into three groups (1) PCC alone (2) FFP alone and (3) PCC and FFP. The primary outcome was the duration from clinical decision to operate to the time of incision. Summary and univariate analyses were performed.ResultsCoagulopathic EGS patients (n = 183) received the following blood products: PCC (n = 20, 11%), FFP alone (n = 119, 65%) and PCC/FFP (n = 44, 24%). The mean (± SD) patient age was 71 ± 13 years; 60% were male. The median (IQR) Charlson comorbidity index was similar in all three groups (PCC = 5(4–6), FFP = 5(4–7), PCC/FFP = 5(4–6), p = 0.33). The mean (± SD) dose of PCC administered was similar in the PCC/FFP group and the PCC alone group (2539 ± 1454 units vs. 3232 ± 1684, p =. 09). The mean (±SD) time to incision in the PCC alone group was significantly lower than the FFP alone group (6.0 ± 3.6 vs. 8.8 ± 5.0 h, p = 0.01). The mean time to incision in the PCC + FFP group was also significantly lower than the FFP alone group (7.1 ± 3.6 vs. 8.8 ± 5.0, p = 0.03). The incidence of thromboembolic complications was similar in all three groups.ConclusionsPCC, alone or in combination with FFP, reduced INR and time to surgery effectively and safely in coagulopathic EGS patients without an apparent increased risk of thromboembolic events, when compared to FFP use alone.Level of evidenceIV single institutional retrospective review.
Excision of Labral Amorphous Calcification as a Part of Hip Arthroscopy—Clinical Outcomes in a Matched‐Controlled Study
Perets, Itay , Hartigan, David E. , Walsh, John P. , Chen, Austin W., Mu, Brian H. , Domb, Benjamin G.

Mayo Clinic

Arthroscopy | February 1, 2018 | Volume: 34 | Issue: 4 | Pages: 1227-1233

10.1016/j.arthro.2017.10.025 | PMID 29395548 Get It

Purpose To evaluate clinical outcomes, demographics, and radiographic findings for patients whose hip arthroscopies involved amorphous calcification (AC) excision and to compare them with a control group with no AC and with the general population regarding diabetes mellitus and hypothyroidism. Methods Patients who underwent primary hip arthroscopy involving surgical excision of AC deposit in the anterosuperior labralcapsular recess between October 2008 and July 2014 were reviewed. Demographics, radiographic findings, intraoperative findings, and procedures were reviewed. Minimum follow‐up was 2 years and included visual analog scale for pain, patient satisfaction, and the following patient‐reported outcome scores: modified Harris hip score, hip outcomes score sport‐specific subscale, and nonarthritic hip score. These patients were matched (1:2 ratio) to patients who underwent hip arthroscopy with no AC using the following matching criteria: age at surgery ± 5 years, body mass index ± 5, gender, type of labral treatment, and type of capsular treatment. Results We reviewed 12 cases in 11 female patients. Mean latest follow‐up scores improved from 64.0 to 83.4 ( P = .003) for modified Harris hip score, from 57.6 to 80.6 ( P < .001) for nonarthritic hip score, from 35.4 to 62.7 ( P = .021) for hip outcomes score sport‐specific subscale, and from 6.4 to 2.8 ( P = .016) for visual analog scale. The survivorship rate was 91.7%, with one hip converting to total hip arthroplasty. Mean patient satisfaction was 8.4 ± 2.3. Six hips of the 12 (50%) had clock face localization of the AC. They were all between 11 and 12 with a mean of 12:30. Postoperative radiographic findings showed no subsequent AC in all 12 hips. No complications or revisions were reported. There were no significant differences between the AC group and the control group. Conclusions The treatment of AC as part of hip arthroscopy for labral tear and femoro‐acetabular impingement is safe and has favorable and similar outcomes compared with a control group at minimum 2‐year follow‐up. Female gender may be a risk factor for the development of AC. There is no strong evidence that AC should be debrided. Level of Evidence Level III, case control study.
Echocardiography in transcatheter aortic valve implantation—Part 1—Transthoracic echocardiography
Naqvi, Tasneem Z.

Mayo Clinic

Echocardiography | February 1, 2018 | Volume: 35 | Issue: 7 | Pages: 1005-1019

10.1111/echo.13799 | PMID 29388705 Get It

Transcatheter aortic valve replacement (TAVR) has been a revolutionary technique in the treatment of degenerative aortic valve stenosis. Selection of appropriate patients and appropriate valve size is crucial for improved patient outcome. Echocardiographic imaging is a critical component for patient selection and plays an important role in the selection of valve size, procedural guidance, and patient follow‐up. This review discusses role of echocardiography in patient selection, device implantation, and postimplant follow‐up for the first‐generation CoreValve as used in pivotal trial. Same TTE imaging principles apply to the second‐ and third‐generation self‐expandable valves as well as the balloon‐expandable valves. Multiple case examples are used to illustrate imaging principles pre‐ and post‐TAVR. In addition, case examples to demonstrate complications post‐TAVR are shown.
Opening a can of worms in AL progression
Dispenzieri, Angela

Mayo Clinic

Blood | February 1, 2018 | Volume: 131 | Issue: 5 | Pages: 475-476

10.1182/blood-2017-11-815423 | PMID 29437606 Get It

Fibrin glue mediated delivery of bone anabolic reagents to enhance healing of tendon to bone
Søreide, Endre , Denbeigh, Janet M. , Lewallen, Eric A. , Samsonraj, Rebekah M. , Berglund, Lawrence J., Dudakovic, Amel , Cool, Simon M. , Nordsletten, Lars , Wijnen, André J. van , van Wijnen, Andre J , Kakar, Sanjeev

Mayo Clinic

Journal of Cellular Biochemistry | February 1, 2018 | Volume: 119 | Issue: 7 | Pages: 5715-5724

10.1002/jcb.26755 | PMID 29388702 Get It

AbstractTendon graft healing in bone tunnels for the fixation of intra‐articular ligament reconstructions may limit clinical outcome by delaying healing. This study assesses the effects of hydrogel‐mediated delivery of bone anabolic growth factors in a validated model of tendon‐to‐bone tunnel healing. Forty‐five Wistar rats were randomly allocated into three groups (BMP2‐treated, GSK126‐treated, and placebo). All animals underwent a tendon‐to‐bone tunnel reconstruction. Healing was evaluated at 4 weeks by biomechanical assessment, micro‐computed tomography (bone mineral density, bone volume, cross sectional area of bone tunnels), and traditional histology. Adverse events associated with the hydrogel‐mediated delivery of drugs were not observed. Results of our biomechanical assessment demonstrated favorable trends in animals treated with bone anabolic factors for energy absorption (P = 0.116) and elongation (P = 0.054), while results for force to failure (P = 0.691) and stiffness (P = 0.404) did not show discernible differences. Cross sectional areas for BMP2‐treated animals were reduced, but neither BMP2 nor GSK126 administration altered bone mineral density (P = 0.492) or bone volume in the bone tunnel. These results suggest a novel and positive effect of bone anabolic factors on tendon‐to‐bone tunnel healing. Histological evaluation confirmed absence of collagen fibers crossing the soft tissue‐bone interface indicating immature graft integration as expected at this time point. Our study indicates that hydrogel‐mediated delivery of BMP2 and GSK126 appears to be safe and has the potential to enhance tendon‐to‐bone tunnel healing in ligament reconstructions.
Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis
Tefferi, Ayalew , Partain, Daniel K. , Palmer, Jeanne , Slack, James L., Litzow, Mark, Patnaik, Mrinal M. , Palmer, Jeanne M., Litzow, Mark L, Patnaik, Mrinal , Partain, Daniel K , Roy, Vivek , Hogan, William J. , Ketterling, Rhett P.

Mayo Clinic

American Journal of Hematology | February 1, 2018 | Volume: 93 | Issue: 5 | Pages: 649-654

10.1002/ajh.25053 | PMID 29388258 Get It

AbstractThe prognostic importance of genetic information in primary myelofibrosis (PMF) was recently highlighted in a study of over 1000 cytogenetically‐annotated patients; 5‐year survival rates were 8% for very high risk (VHR), 27% “unfavorable” and 45% “favorable” karyotype. The current study addresses the practice‐relevant question of whether or not allogeneic hematopoietic stem cell transplant (HCT) can overcome the detrimental survival effect of VHR or unfavorable karyotype. The study included 67 patients with PMF or secondary MF who received HCT at the Mayo Clinic and in whom pretransplant cytogenetic information was available. Dynamic international prognostic scoring system (DIPSS) risk distribution was 13% high, 66% intermediate‐2 and 21% intermediate‐1. Cytogenetic risk distribution was 11% VHR, 34% unfavorable and 55% favorable. At median post‐HCT follow‐up of 60 months for living patients (range 34‐170), 28 (42%) deaths were recorded. Five‐year survival was 62% and was not affected by VHR or unfavorable karyotype (P = .68). The salutary effect of HCT in patients with VHR or unfavorable karyotype was also apparent during analysis of a combined dataset that included a nontransplant cohort of 383 patients with PMF; multivariable analysis of the combined dataset (n = 450) resulted in HRs (95% CI) of 2.4 (1.6‐3.6) for absence of transplant, 3.3 (2.2‐4.8) for VHR karyotype, 1.6 (1.2‐2.1) for unfavorable karyotype, 2.9 (2.0‐4.2) for DIPSS high and 1.7 (1.4‐2.2) for DIPSS intermediate‐2. These observations were further confirmed by analysis of more stringently matched case‐control subset cohorts and provide the evidence for the therapeutic preference of HCT in cytogenetically high risk patients with MF.
Letting the Patient Decide: A Case Report of Self-Administered Sedation During Mechanical Ventilation
Hetland, Breanna , Hayes, Sarah , Skaar, Debra J. , Tracy, Mary Fran , Weinert, Craig , Hayes, Sarah Maryon, Skaar, Debra, Weinert, Craig R, CHLAN, LINDA, Chlan, Linda L.

Mayo Clinic

Critical Care Nurse | February 1, 2018 | Volume: 38 | Issue: 1 | Pages: 17-23

10.4037/ccn2018676 | PMID 29437074 Get It

It is common for critical care nurses to administer sedative medications to patients receiving mechanical ventilation. Although patient-controlled analgesia is frequently used in practice to promote effective self-management of pain by patients, it is not known if patient-controlled sedation can be used to promote effective self-management of distressing symptoms associated with mechanical ventilation. A randomized pilot trial was conducted to evaluate whether patient self-administered sedation with dexmedetomidine is safe and acceptable for self-management of anxiety during ventilator support. This case report details the experiences of one patient enrolled in the pilot trial who was randomly assigned to the experimental dexmedetomidine intervention, completed the study protocol, and provided feedback. In a poststudy survey, the patient responded positively to the use of self-administered sedation with dexmedetomidine during ventilator support.
Left Axis Deviation in Children Without Previously Known Heart Disease
Schneider, Andrew E. , Cannon, Bryan C. , Johnson, Jonathan N. , Ackerman, Michael J. , Wackel, Philip L.

Mayo Clinic

Pediatrics | February 1, 2018 | Volume: 141 | Issue: 3 | Pages: No page available

10.1542/peds.2017-1970 | PMID 29437138 Get It

BACKGROUND: Left axis deviation (LAD) discovered in children via electrocardiogram (ECG) is uncommon but can be associated with heart disease (HD). The optimal diagnostic approach in a seemingly healthy child with LAD is unclear. We sought to better stratify which patients with LAD but without previously known HD may warrant additional workup. METHODS: A retrospective chart review was performed to identify patients ≥1 to &lt;18 years of age with LAD (QRS frontal plane axis 0 to −90) on an ECG between January 2002 and December 2014. Patients with known HD before their initial ECG were excluded. RESULTS: Overall, 296 patients were identified (n = 181 [61%] male; mean age: 10.8 ± 4.6 years; mean QRS axis: −24 ± 22°). An echocardiogram was performed in 158 (53%) patients, with 24 (15%) having HD. Compared with those with an echocardiogram but without HD (n = 134), patients with HD had a more negative mean QRS axis (−42 vs −27°; P = .002) and were more likely to have a QRS axis ≤−42° (58% vs 26%; P = .003), ECG chamber enlargement or hypertrophy (38% vs 5%; P &lt; .0001), and abnormal cardiac physical examination findings (75% vs 8%; P &lt; .0001). CONCLUSIONS: LAD discovered in isolation in the asymptomatic pediatric patient may not necessitate further cardiovascular investigation. Clinicians should consider obtaining an echocardiogram in patients with LAD and ECG cardiac chamber enlargement or hypertrophy, a QRS axis ≤−42°, and/or the presence of abnormal cardiac physical examination findings.